When Should You Buy GLOBALFOUNDRIES Inc. (NASDAQ:GFS)?
When Should You Buy GLOBALFOUNDRIES Inc. (NASDAQ:GFS)?
Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) receives FDA BsUFA date of October 29, 2026 for its investigational biosimilar candidate to LUCENTIS® (ranibizumab)
Xiao-I regains compliance with Nasdaq listing standards
We Think Workday's (NASDAQ:WDAY) Robust Earnings Are Conservative
First day of trading in Aira’s shares on Nasdaq First North Growth Market
Turbo Energy stock jumps on Nasdaq compliance progress
Nasdaq Resumes Trading in TJGC Group Limited
Update on the Proposed Dual Listing on the Nasdaq Stock Market
Reliance Global Group regains Nasdaq $1.00 minimum bid compliance after May rally
Nasdaq 100 hits fresh record despite Brent rising for third straight day as USD/JPY hits Y160